Compositions and methods for treating cns disorders
US-2026098053-A1 · Apr 9, 2026 · US
This page is not indexed by search engines while we improve data quality.
Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms
Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07J61/00 |
| Official title | Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms |
| Display label | Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms |
| Total patents | 20 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Compositions and methods for treating CNS disorders
US-12552829-B2 · Feb 17, 2026 · US
Compositions and methods for treating cns disorders
US-2025171492-A1 · May 29, 2025 · US
Compositions and methods for treating cns disorders
US-2024101592-A1 · Mar 28, 2024 · US
Compositions and methods for treating cns disorders
US-2023303616-A9 · Sep 28, 2023 · US
Steroid derivative regulators, method for preparing the same, and uses thereof
US-11661437-B2 · May 30, 2023 · US
Compositions and methods for treating cns disorders
US-2023085354-A1 · Mar 16, 2023 · US
Compositions and methods for treating cns disorders
US-2022380405-A1 · Dec 1, 2022 · US
Compositions and methods for treating cns disorders
US-2022315621-A1 · Oct 6, 2022 · US
Steroid derivative regulators, method for preparing the same, and uses thereof
US-2022017565-A1 · Jan 20, 2022 · US
Isolation of cyclopamine
US-2019263852-A1 · Aug 29, 2019 · US
Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for GABA type-A receptors
US-10202413-B2 · Feb 12, 2019 · US
Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)dien-28-oyl) imidazole
US-9896475-B2 · Feb 20, 2018 · US
Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)dien-28-oyl) imidazole
US-2017267713-A1 · Sep 21, 2017 · US
Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for gaba type-a receptors
US-2016251391-A9 · Sep 1, 2016 · US
Synthesis of ent-progesterone and intermediates thereof
US-2016168188-A1 · Jun 16, 2016 · US
Isolation of Cyclopamine
US-2016168193-A1 · Jun 16, 2016 · US
Synthesis of ent-progesterone and intermediates thereof
US-2016108081-A1 · Apr 21, 2016 · US
Synthesis of ent-progesterone and intermediates thereof
US-2016016988-A1 · Jan 21, 2016 · US
Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for gaba type-a receptors
US-2015361125-A1 · Dec 17, 2015 · US